Raditya M Nova, Bagus A M Made, Kustiati Ulayatul, Wihadmadyatami Hevi, Kusindarta Dwi Liliek
Department of Anatomy, Faculty of Veterinary Medicine, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Integrated Laboratory for Research and Testing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Data Brief. 2020 Apr 30;30:105654. doi: 10.1016/j.dib.2020.105654. eCollection 2020 Jun.
The article offers dataset on the expression of serotonergic nerve in the hippocampal area of Alzheimer's disease (AD) model. Since decreasing expression of serotonin linked to dementia, this data will help the neuroscientist, who work on neurodegeneration. This dataset demonstrates the potential of Extract (OSE) as a neuroprotective and neurodegenerative agent against AD. The OSE mechanism focusing on the expression of serotonin as a therapeutic target. To acquire the dataset, we approached using two models, in vitro and in vivo. On the In vivo model, used two months old 27 male rats and divided into three groups, non-treated (Group A, n=9), AD rats model pre-treated with OSE followed induction for TMT on the days of seventh (group B, n=9) and AD rats model treated with OSE both on pre-TMT introduction for seven days and post-TMT induction for 21 days (group C, n=9). AD rats euthanised on day seventh; 14th; and 21st. The brain samples were analysed for neuronal density and serotonin immunoreactivity qualitatively. Besides, In Vitro's data were collected from HEK-293 cells which induce by TMT as of AD model. The data expression of serotonin on the in-vitro model analysed using ELISA method.
本文提供了关于阿尔茨海默病(AD)模型海马区5-羟色胺能神经表达的数据集。由于5-羟色胺表达降低与痴呆症相关,这些数据将有助于从事神经退行性变研究的神经科学家。该数据集证明了提取物(OSE)作为一种针对AD的神经保护和神经退行性变药物的潜力。OSE机制聚焦于将5-羟色胺的表达作为治疗靶点。为获取该数据集,我们采用了体外和体内两种模型。在体内模型中,使用了27只两个月大的雄性大鼠,分为三组:未处理组(A组,n = 9);在第7天用OSE预处理后再诱导TMT的AD大鼠模型(B组,n = 9);在TMT引入前7天和TMT诱导后21天均用OSE处理的AD大鼠模型(C组,n = 9)。在第7天、第14天和第21天对AD大鼠实施安乐死。对脑样本进行神经元密度和5-羟色胺免疫反应性的定性分析。此外,体外数据是从作为AD模型由TMT诱导的HEK-293细胞中收集的。使用ELISA方法分析体外模型中5-羟色胺的数据表达。